| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
|---|
| 06/28/2000 | EP1012145A1 Alkoxy-substituted compounds, methods, and compositions for inhibiting parp activity |
| 06/28/2000 | EP1011726A2 Fused imidazole derivatives for improving oral bioavailability of pharmaceutical agents |
| 06/28/2000 | EP1011648A2 Combination of tyrosine kinase inhibitor and chemical castration to treat prostate cancer |
| 06/28/2000 | CN1258283A Cyclic diamine compounds and medicine contg. same |
| 06/28/2000 | CN1053907C Process for manufacture of tricyclic compound |
| 06/28/2000 | CN1053905C Oxadiazine derivs., their preparing process and use, intermediates for preparing same |
| 06/27/2000 | US6080858 Reacting amine compounds with fluorine-substituted triazine or pyrimidine groups to make dyes having fluorine-substituted triazine or pyrimidine group as fiber-reactive component; presence of phase transfer catalyst improves purity, yield |
| 06/27/2000 | US6080855 2-isocephem and oxacephem derivatives and use as antibacterial agents |
| 06/27/2000 | US6080773 Benzylamine derivatives which are useful in treating psychiatric disorders |
| 06/27/2000 | US6080764 Superoxide radical inhibitor |
| 06/27/2000 | US6080740 Spiro-ketal derivatives and their use as therapeutic agents |
| 06/22/2000 | WO2000035920A2 4,5-azolo-oxindoles |
| 06/22/2000 | WO2000035915A1 Piperazine derivatives |
| 06/22/2000 | WO2000035408A2 Method for treatment of bacterial infections with once or twice-weekly administered rifalazil |
| 06/22/2000 | CA2354875A1 Piperazine derivatives |
| 06/22/2000 | CA2293023A1 Process for producing ucn-01 |
| 06/21/2000 | EP1009749A1 Preparation of (s)-n-tert-butyl-1,2,3,4-tetrahydroisoquinoline-3-carboxyamide |
| 06/21/2000 | EP1009742A1 5,5-disubstituted-1,5-dihydro-4,1-benzoxazepin-2(3h)-ones useful as hiv reverse transcriptase inhibitors |
| 06/21/2000 | EP1009739A2 Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity |
| 06/21/2000 | EP1009738A1 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| 06/21/2000 | CN1053666C Benzoheterocylic compounds and process for preparing medicated salt thereof |
| 06/20/2000 | CA1341035C Macrocyclic polyaza compounds containing 5 or 6 membered rings, process for producing them and pharmaceutical media containing them. |
| 06/20/2000 | CA1341029C Peptidase inhibitors |
| 06/15/2000 | WO2000034239A2 Inhibitors of prenyl-protein transferase |
| 06/15/2000 | WO2000033878A2 Stabilization of macrolides |
| 06/15/2000 | DE19857273A1 Fungicides comprising 2-oxa-1,3,6,7-tetraaza-cyclopenta (a) naphthalene derivatives, useful in human or veterinary medicine, wood protection or especially plant protection, effective e.g. against rice blast |
| 06/15/2000 | CA2732620A1 Crystalline form of 40-o-(2-hydroxy-ethyl) rapamycin and process for preparation thereof |
| 06/15/2000 | CA2651609A1 Crystalline form of 40-o- (2-hydroxy-ethyl) rapamycin and process for preparation thereof |
| 06/14/2000 | EP1007518A1 Solid and liquid-phase synthesis of benzoxazoles and benzothiazoles and their use |
| 06/14/2000 | EP1007042A1 Novel heteroaryl compounds for the modulation of protein tyrosine enzyme related cellular signal transduction |
| 06/14/2000 | EP0830145B1 Formulations comprising leflunomide |
| 06/14/2000 | EP0525057B1 Antimicrobial quinolonyl lactams |
| 06/14/2000 | CN1053448C Compound useful as antiproliferative agents and GARFT inhibitors |
| 06/13/2000 | US6075034 Spiro[piperidine-4,1'-pyrrolo [3,4-C] pyrrole]derivatives |
| 06/07/2000 | EP1005468A1 Antibiotic oxazolidinone derivatives |
| 06/07/2000 | EP1005356A1 Novel antibacterial agents |
| 06/06/2000 | US6072054 Cyclic aryl ethers, thioethers, and amines and method preparation |
| 06/06/2000 | US6071925 Antidepressants, anticonvulsants or antianxiety agents, also for treatment of memory loss in alzheimer's disease |
| 06/06/2000 | US6071906 Inhibits or modulates the inducible isoform of nitric oxide synthase over the the constitutive isoforms; antiarthritic, -diabetic, ischemic, thrombosis agents; cardiovascular disorders; toxic shock syndrome; autoimmune diseases |
| 06/06/2000 | US6071895 Polar-substituted hydrocarbons |
| 06/02/2000 | WO2000031247A2 Recombinant methods and materials for producing epothilone and epothilone derivatives |
| 06/02/2000 | WO2000031062A1 Cycloalkyl-substituted aminomethylpyrrolidine derivatives |
| 06/02/2000 | WO2000031037A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 06/02/2000 | WO2000030651A1 Use of staurosporine derivatives for treating ocular neovascular diseases |
| 06/02/2000 | WO2000030646A1 Heterocyclic compounds regulating clotting |
| 06/02/2000 | WO2000030639A1 Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system |
| 06/02/2000 | CA2352526A1 Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system |
| 06/02/2000 | CA2351865A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 06/02/2000 | CA2351497A1 Cycloalkyl-substituted aminomethylpyrrolidine derivative |
| 06/02/2000 | CA2350189A1 Recombinant methods and materials for producing epothilone and epothilone derivatives |
| 05/31/2000 | EP1003751A1 Hydroxamic acid substituted fused heterocyclic metalloproteinase inhibitors |
| 05/31/2000 | EP1003541A1 Inhibitors of hiv reverse transcriptase |
| 05/31/2000 | CN1255126A Heterocyclically substituted aromatic amino compounds with herbicidal effect |
| 05/30/2000 | US6069245 Asymmetric synthesis of azepines |
| 05/25/2000 | DE19854147A1 Control of cocaine addiction comprises administration of N-substituted azabicycloalkane derivative |
| 05/24/2000 | EP1002534A1 Bis-Staurosporine and K-252a derivatives |
| 05/24/2000 | EP1001970A1 Dipeptide derivatives as growth hormone secretagogues |
| 05/24/2000 | EP1001940A1 Condensed pyrazole compounds |
| 05/24/2000 | EP1001782A1 5,6-HETEROARYL-DIPYRIDO 2,3-$i(b):3',2'-$i(f)]AZEPINES AND THEIR USE IN THE PREVENTION OR TREATMENT OF HIV INFECTION |
| 05/24/2000 | EP0931083A4 Process for producing ecteinascidin compounds |
| 05/23/2000 | US6066658 For prevention and treatment of bone diseases such as osteoporosis, bone fractures, osteoarthritis and rheumatoid arthritis, arteriosclerosis, cancer metastasis, and diseases based on nerve degeneration |
| 05/23/2000 | US6066646 Insecticidal, acaricidal or nematicidal composition |
| 05/18/2000 | WO2000028011A2 Fk506-based regulation of biological events |
| 05/18/2000 | WO2000027851A1 Novel type condensed pyridazinone compounds |
| 05/18/2000 | CA2346962A1 Fk506-based regulation of biological events |
| 05/17/2000 | EP1000617A2 Treatment of platelet derived growth factor related disorders such as cancers using inhibitors of platelet derived growth receptor |
| 05/17/2000 | EP1000059A1 Tricyclic vasopressin agonists |
| 05/17/2000 | EP1000040A1 Il-5 inhibiting 6-azauracil derivatives |
| 05/17/2000 | EP0804191B1 Use of inhibitors of platelet derived growth receptor for the manufacture of a medicament for the treatment of cancers |
| 05/16/2000 | US6063918 Reacting a base with a 2-azetidinyl-3,4-dihalogeno-2-butenoic acid compound in an aqueous organic solvent to yield a cyclized isooxacephalosporin derivative; simplification |
| 05/16/2000 | US6063774 Tricyclic quinoxaline derivatives as neuroprotective agents |
| 05/16/2000 | US6063625 Regulated transcription of targeted genes and other biological events |
| 05/16/2000 | CA2011658C New 1,7-annelated 1h-indole-2-carboxylic acid-n-(1,4-benzodiazepin-3-yl) amides |
| 05/11/2000 | WO2000025788A1 Inhibitors of prenyl-protein transferase |
| 05/11/2000 | WO2000025721A2 Sodium salt of 3-(4-cinnamyl-1-piperazinyl)imino-methyl rifamycin sv and process of preparation |
| 05/11/2000 | CA2348703A1 Inhibitors of prenyl-protein transferase |
| 05/10/2000 | CN1252721A Pharmaceutical composition |
| 05/10/2000 | CN1052231C 2-oxo-5-oxazolidone methyl compound their preparing method and medicinal composition containing them |
| 05/09/2000 | CA2181168C Antiparasitic pyrrolobenzoxazine compounds |
| 05/04/2000 | WO2000024746A1 Thienooxazines as nos-inhibitors |
| 05/04/2000 | WO1999063988A9 Inhibitors of nitric oxide synthase |
| 05/03/2000 | EP0997466A1 Novel antimicrobial lactam-quinolones |
| 05/03/2000 | EP0997153A1 Formulations for lipophilic compounds |
| 05/02/2000 | US6057440 Process for preparing bis-indoly macrocycles |
| 05/02/2000 | US6057325 Have central dopamine and serotonin antogonistic activity |
| 05/02/2000 | US6057317 Heterocyclic compounds |
| 05/02/2000 | US6057315 Antibacterial agents |
| 05/02/2000 | US6057314 Anticoagulants |
| 04/27/2000 | WO2000023451A1 New compounds, their preparation and use |
| 04/27/2000 | WO2000023437A1 Nitrogenous fused heterocycle compounds, process for the preparation thereof and agents containing the same |
| 04/27/2000 | CA2347095A1 Nitrogen-containing condensed heterocyclic derivatives, their production and agent |
| 04/26/2000 | EP0994880A1 Crystalline macrolides and process for their preparation |
| 04/26/2000 | EP0994879A1 Photochromatic compounds, process for their preparation and their use in polymeric materials |
| 04/26/2000 | EP0994693A2 Storage-stable ophthalmic compositions comprising diclofenac and ofloxacin |
| 04/26/2000 | EP0827504B1 Process for manufacturing clavulanic acid salt |
| 04/26/2000 | EP0802913B1 IMIDAZO [4,5-c]QUINOLINE AMINES |
| 04/26/2000 | EP0777671B1 Spiro-azabicyclic compounds useful in therapy |
| 04/26/2000 | CN1251588A Novel 3,5 and/or 6 substituted analogues of swainsonine, process for their preparation and their use as therapeutic agents |
| 04/26/2000 | CN1251579A Compound and compositions for treating diseases associated with serine protease, particularly tryptase, activity |
| 04/25/2000 | US6054459 Insecticides and ectoparasiticides |